A very hopeful article was recently released from AboutMesothelioma.net. It described a treatment, multi-pronged treatment, that may improve survival for mesothelioma patients. This hope extends to patients with stage I through III pleural mesothelioma lung cancer.

This recently released article describes a new study from the Journal of Clinical Oncology reports findings that suggest that the survival rate of the above mentioned patient demographis may improve by using a battery of different forms of treatments, including chemotherapy prior to surgery.

About Mesothelioma

Mesothelioma is a rare kind of cancer that is intimately correlated with exposure to asbestos. Many mesothelioma law suits have been fought to demonstrate the link between asbestos and mesothelioma. It is now strongly suggested that exposure to asbestos causes the development of several asbestos-related illnesses; lung cancer, asbestosis and malignant pleural mesothelioma. The problem that many who are afflicted by this are now experiencing is that those exposed do not experience symptoms until at least 10 – 50 years have passed, resulting in a multitude of mesothelioma lawsuits several years after exposure.

Mesothelioma & Multi-Pronged Treatment

The new treatment that is being advocated, multi-pronged treatment, involves several steps to the actual treatment, hence the name for the treatment. Researchers began this treatment by administering chemotherapy before surgery using the medications Alimta and Platinol with the aim of first reducing the size of the cancer. The next step is surgery to remove the diseased lung which is described as the second phase of the multi-pronged approach.

The final phase of this approach involves receiving radiation therapy. This study reported strong statistics supporting the hope that this treatment will improve survival rates among mesothelioma patients.

Those participants in this study that underwent all three phases of the multi-pronged treatment had a two-year survival rate of 61% which is a vast improvement over previous rates. The conclusion of researchers involved in this study is that it produced reasonable long-term survival results.